FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37397411000001107: DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jul 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
311291000001113 DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
311301000001112 DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Is a Budesonide 200micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler false Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Is a DuoResp Spiromax true Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Formoterol fumarate dihydrate true Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - patient training required false Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Budesonide true Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Is a Budesonide 200micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler true Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Is a Budesonide+eformoterol fumarate 200/6mcg breath-actuated dry powder inhaler false Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) 120 dose Has AMP True DuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhaler (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start